Literature DB >> 9503506

Collecting duct carcinoma of kidney.

J R Srigley1, J N Eble.   

Abstract

Collecting duct carcinoma of the kidney is a rare neoplasm with only approximately 100 cases described in the literature to date. The tumor occurs in a wide age range and predominantly in males. Typical collecting duct carcinoma consists of a grossly infiltrative neoplasm centered on the renal medulla. The usual histological pattern is that of a tubular or tubulopapillary carcinoma with a desmoplastic stroma that often contains neutrophils. Less commonly, collecting duct carcinoma has a papillary architecture with desmoplasia and infiltrative growth. Collecting duct carcinoma spread aggressively and many patients have metastases at the time of presentation. Origin in the collecting duct is suggested by medullary location, dysplasia of the epithelium in collecting ducts outside the tumor, and reactivity with antibody to high molecular weight cytokeratin and Ulex europaeus agglutinin. No unifying cytogenetic or molecular genetic features have been discovered thus far. The concept of collecting duct carcinoma is expanding and should include the recently described renal medullary carcinoma that is associated with sickle cell trait.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9503506

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  29 in total

1.  Metastatic collecting duct carcinoma of the kidney responded to sunitinib.

Authors:  Hideaki Miyake; Takahiro Haraguchi; Atsushi Takenaka; Masato Fujisawa
Journal:  Int J Clin Oncol       Date:  2010-08-05       Impact factor: 3.402

2.  Is there a role for targeted therapies in the collecting ducts of Bellini carcinoma? Efficacy data from a retrospective analysis of 7 cases.

Authors:  Giuseppe Procopio; Elena Verzoni; Roberto Iacovelli; Maurizio Colecchia; Tullio Torelli; Luigi Mariani
Journal:  Clin Exp Nephrol       Date:  2012-01-26       Impact factor: 2.801

3.  Metastatic collecting duct carcinoma of the kidney treated with sunitinib.

Authors:  El Mehdi Tazi; Ismail Essadi; Mohamed Fadl Tazi; Youness Ahellal; Hind M'rabti; Hassan Errihani
Journal:  World J Surg Oncol       Date:  2011-07-13       Impact factor: 2.754

4.  Renal medullary carcinoma.

Authors:  Muhammad Ahsan Baig; Yu-Shia Lin; Javeria Rasheed; Neal Mittman
Journal:  J Natl Med Assoc       Date:  2006-07       Impact factor: 1.798

5.  Aggressive co-existence: Collecting duct and clear cell carcinoma in the same kidney.

Authors:  Abdullah Hızır Yavuzsan; Mithat Ekşi; Fırat Baytekin; Volkan Tuğcu
Journal:  Turk J Urol       Date:  2018-12-19

6.  Clinicopathological characteristics of kidney mucinous tubular and spindle cell carcinoma.

Authors:  Qian Chen; Yonghong Gu; Binghui Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

7.  Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma.

Authors:  Won K Han; Anwar Alinani; Chin-Lee Wu; Dror Michaelson; Massimo Loda; Francis J McGovern; Ravi Thadhani; Joseph V Bonventre
Journal:  J Am Soc Nephrol       Date:  2005-03-02       Impact factor: 10.121

8.  Collecting duct carcinoma: an entity to be redefined?

Authors:  Hélène Kafé; Jean-Marc Verbavatz; Béatrix Cochand-Priollet; Patrice Castagnet; Annick Vieillefond
Journal:  Virchows Arch       Date:  2004-10-08       Impact factor: 4.064

9.  Effect of collecting duct histology on renal cell cancer outcome.

Authors:  Jonathan L Wright; Michael C Risk; James Hotaling; Daniel W Lin
Journal:  J Urol       Date:  2009-12       Impact factor: 7.450

10.  Tubulocystic carcinoma of the kidney: a histologic, immunohistochemical, and ultrastructural study.

Authors:  Borislav A Alexiev; Cinthia B Drachenberg
Journal:  Virchows Arch       Date:  2013-03-24       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.